Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.10.4233

Relationship of Body Mass Index with Prognosis in Breast Cancer Patients Treated with Adjuvant Radiotherapy and Chemotherapy  

Cihan, Yasemin Benderli (Department of Radiation Oncology, Kayseri Education and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.10, 2014 , pp. 4233-4238 More about this Journal
Abstract
Background: The aim of this study was to investigate the relationship of body mass index with overall and progression-free survival as well as other prognostic factors of breast cancer in patients with non-metastatic breast cancer. Materials and Methods: We retrospectively reviewed 456 patients diagnosed with breast cancer in the Radiation Oncology department of Kayseri Teaching Hospital between 2005 and 2013. We investigated relationship of body mass index with prognosis and other prognostic factors. Results: The study included 456 patients (447 women and 9 men). Mean age at presentation was 55.6 years. Of the cases, 96.9% underwent modified radical mastectomy and 95.0% received chemotherapy, while 82.4% received radiotherapy and 60.0% were given hormone therapy. Body mass index was >25 mg/kg2 in 343 cases. Five- and 10-years overall survival rates were 77% and 58% whereas progression-free survival rates were 65% and 49%, respectively. In univariate analyses, factors including stage (p=0.046), tumor diameter (p=0.001), lymph node metastasis (p=0.006) and body mass index (p=0.030) were found to be significantly associated with overall survival, while perinodal involvement was found to be significantly associated with progression-free survival (p=0.018). In multivariate analysis, stage (p=0.032; OR: 3.8; 95% CI: 1.1-13), tumor diameter (p<0.000; OR: 0.0; 95% CI: 0.0-0.3), lymph node metastasis (p=0.005; OR: 0.0; 95% CI: 0.0-0.5) and BMI (p=0.027; OR: 0.02; 95% CI: 0.0-0.8) remained as significantly associated with OS. Conclusions: In our study, it was seen that overall survival time was shorter in underweight and obese patients when compared to normal weight patients.
Keywords
Breast cancer; body mass index; prognosis;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 Alegre MM, Knowles MH, Robison RA, O'Neill KL (2013). Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12.   과학기술학회마을   DOI   ScienceOn
2 Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35.   DOI
3 Olmez OF, Evrensel T, Cubukcu E, et al (2013). Prognostic significance of human epidermal receptor (HER)- 3 immunohistochemical expression in patients with metastatic breast cancer. Asian Pac J Cancer Prev, 14, 4115-9.   과학기술학회마을   DOI   ScienceOn
4 Parekh N, Chandran U, Bandera EV (2012). Obesity in cancer survival. Annu Rev Nutr, 32, 311-42.   DOI
5 Petrelli JM, Calle EE, Rodriquez C, Thun MJ (2002). Body mass index, height and postemenapausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control, 13, 325-32.   DOI
6 Ryu SY, Kim CB, Nam CM, et al (2001). Is body mass index the prognostic factor in breast cancer? a meta-analysis. J Korean Med Sci, 16, 610-4.   과학기술학회마을   DOI
7 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 283-98.   DOI   ScienceOn
8 Suleeporn S, Arkom C, Pattama P, et al (2013). Obesity, diet and physical inactivity and risk of breast cancer in Thai women. Asian Pac J Cancer Prev, 14, 7023-7.   과학기술학회마을   DOI   ScienceOn
9 Tanriverdi O, Meydan N, Barutca S (2014). Reconsideration of clinical and histopathological prognostic factors in breast cancer patients: a single center experience.. Asian Pac J Cancer Prev, 15, 807-12.   과학기술학회마을   DOI
10 Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32.   과학기술학회마을   DOI
11 Ewertz M, Jensen MB, Gunnarsdottir KA, et al (2011). Effect of obesity on prognosis after early stage breast cancer. J Clin Oncol, 29, 25-31.   DOI   ScienceOn
12 Berclaz G, Li S, Price KN, et al (2004). Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol, 15, 875-84.   DOI   ScienceOn
13 de Azambuja E, McCaskill-Stevens W, Francis P, et al (2010). The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat, 119, 145-53.   DOI
14 Engin H, Bilir C, Tekin IO (2013). Prognostic significance of peripheral blood flow cytometry parameters in patients with non-metastatic breast cancer.. Asian Pac J Cancer Prev, 14, 7645-9.   과학기술학회마을   DOI   ScienceOn
15 Goodwin P (2013). Obesity and endocrine therapy: Host factors and breast cancer outcome. The Breast, 22, 44-7.   DOI
16 Griggs JJ, Sorbero ME, Lyman GH (2005). Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med, 165, 1267-73.   DOI
17 Malcolm AM, Yasantha A, Farhana B, et al (2009). Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev, 10, 49-67.
18 Taghavi A, Fazeli Z, Vahedi M, et al (2012). Incidence trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70.   DOI   ScienceOn
19 Ademuyiwa F, Groman A, O'Connor T, et al (2011). Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer, 117, 4132-40.   DOI
20 Klimant E, Glurich I, Mukesh B, Onitilo A (2011). Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: A retrospective study exploring relationships in a phenotypically well-defined cohort. Clin Med & Res, 9, 111-8.   DOI
21 Sestak I, Distler W, Forbes JF, et al (2010). Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol, 28, 3411-5.   DOI
22 Ladoire S, Dalban C, Roche H, et al (2014). Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: A pooled analysis of two randomised trials. Eur J Cancer, 50, 506-16.   DOI